Senate Health & Human Services
Sen. Barbara Kirkmeyer's bid to let the governor temporarily classify emerging drug analogs died in Senate Health & Human Services after members balked at vesting Schedule 2 authority in one office. The committee then quietly closed the books on a kidney-disease task force its own witness called a 'sunset success story.'
Key Actions
+ 1 more action
Notable Quotes
“Now, it is very narrow what the governor can do and how far he can go. It's not like we're giving him broad authority, because I know there are some of you that are thinking, why would a Republican think that it's okay to get the governor additional authority?”
+ 3 more quotes
Votes
Subscribe to see every key action, the full discussion, amendments, and notable quotes.
Sign in to subscribeIf they're able to make it two, they're both online, right? Senate Health and Human Services will come to order. Mr. Brown, please call the roll. Senators Bright. Here. Cutter. Excused. Doherty. Here. Frizzell Excused. Weissman. Good morning, Judah. President. Mr. Chair Mullica here. Members, we have two bills on the calendar. First bill is up is Senate Bill 99. We have Senator Kirkmeyer with us. Let the record reflect that Senator Frizzell has joined us. Senator Kirkmeyer, you want to tell us a little bit about Senate Bill 99? Yep, I do. Thank you, Mr. Chair. I appreciate it. And hopefully we don't have a deja vu from the last time I was here. Anyways, thank you for your patience with me. I greatly appreciate it and the ability to go ahead and respond. Schedule is for today and I'm thankful for the people that are going to be witnesses in this as well. So right now, currently under law, any material, compound, mixture or preparation which is an analog or has a similar chemical structure to and is designed to produce a similar or greater effect of a Schedule 2 drug is treated the same as a Schedule…
Subscribe to unlock the full transcript, summary, and search across all Colorado committee hearings.
Sign in to subscribe